Arca Biopharma | ABIO - Nettoeinkommen

Aktienkurs
41.56
Täglich Wechseln
2.65 6.81%
Monatlich
16.87%
Jährlich
236.25%
Q1 Prognose
37.74




Nettoeinkommen Veränderung Datum
Alterity Therapeutics Limited AUD -5.77M 2.26M 2023-06
Amgen USD 1.33B 1.88B 2025-12
Arca Biopharma USD -29.58M 694K 2025-12
Biogen USD 466.5M 168.3M 2025-09
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cipla INR 6.76B 6.75B 2025-12
Clal Biotechnology ILS -6.17M 15.56M 2022-12
Compugen USD 56.84M 63.82M 2025-12
CSL USD 401M 96.5M 2025-12
Cytokinetics USD -183.03M 123.15M 2025-12
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Grifols EUR 114.37M 34.03M 2025-12
Laboratory Of America USD 164.7M 96.4M 2025-12
Myriad Genetics USD -7.9M 19.5M 2025-12
Otsuka Holdings JPY 65.49B 58.64B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
United Therapeutics USD 364.3M 25.6M 2025-12